BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| (2->1)-beta-D-fructofuranan {Inulin} - Rikenellaceae |
👪
Inulin accelerates weight loss in obese mice by regulating gut microbiota and serum metabolites. Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 980382 Pub: 2022 Epub: 2022 Sep 28 Authors Wu Z , Du Z , Tian Y , Liu M , Zhu K , Zhao Y , Wang H , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Rikenellaceae |
👪
Dietary Supplementation with Inulin Modulates the Gut Microbiota and Improves Insulin Sensitivity in Prediabetes. International journal of endocrinology (Int J Endocrinol ) Vol: 2021 Issue Pages: 5579369 Pub: 2021 Epub: 2021 Jun 29 Authors Wang X , Wang T , Zhang Q , Xu L , Xiao X , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Rikenellaceae |
👪
Modulation of Human Gut Microbiota In Vitro by Inulin-Type Fructan from Codonopsis pilosula Roots. Indian journal of microbiology (Indian J Microbiol ) Vol: 64 Issue 2 Pages: 520-528 Pub: 2024 Jun Epub: 2024 Feb 6 Authors Li J , Cao L , Ji J , Shen M , Gao J , Html Article Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Rikenellaceae |
📓
Inulin has a beneficial effect by modulating the intestinal microbiome in a BALB/c mouse model. Beneficial microbes (Benef Microbes ) Vol: 14 Issue 4 Pages: 371-383 Pub: 2023 Sep 1 Epub: 2023 Sep 1 Authors Zhu Z , Hu C , Liu Y , Wang F , Zhu B , Publication |
| (2->1)-beta-D-fructofuranan {Inulin} - Rikenellaceae |
👪
Alterations of gut microbiome and metabolism induced by inulin associated with weight loss in obese female mice. International journal of food sciences and nutrition (Int J Food Sci Nutr ) Vol: 74 Issue 5 Pages: 606-620 Pub: 2023 Sep Epub: 2023 Jul 19 Authors Wu Z , Zhang M , Deng Y , Zhou G , Yang M , Wang H , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
